NAD+ × myaminolab peptides — lab test, July 2026
COA KVR-2026-FF1EF2 matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
BFJTU0VTest results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 500 mg · Lab measured 493.16 mg
99% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 123.3 mg using the measured mass, against 125 mg on the label — 1% less.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-FF1EF2 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 8 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of NAD+ from myaminolab peptides, performed by Kovera Labs on July 6, 2026. Reported purity: 99.886%. Net content: 493.16 mg against 500 mg labeled (99% of label). Batch V2606-N500-2401. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion